2016
DOI: 10.5603/ep.a2016.0014
|View full text |Cite
|
Sign up to set email alerts
|

Ocena stężeń OPG, RANKL i markerów obrotu kostnego w surowicy oraz BMD u pacjentek leczonych z powodu osteoporozy pomenopauzalnej ranelinianem strontu i ibandronianem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…For postmenopausal osteoporosis, oestrogen deficiency leads to upregulation of receptor activator of nuclear factor-kappa ligand (RANKL) and tumour necrosis factor-α, resulting in excessive bone resorption and rapid bone loss. 14 For senile osteoporosis, there is also a significant reduction in bone formation due to osteoblastic dysfunction. Osteoblasts and adipocytes both differentiate from mesenchymal stem cells (MSCs), and there is a shift from osteoblastogenesis to adipogenesis in the bone marrow with increasing age, causing reduction in the life span of osteoblasts.…”
Section: Introductionmentioning
confidence: 99%
“…For postmenopausal osteoporosis, oestrogen deficiency leads to upregulation of receptor activator of nuclear factor-kappa ligand (RANKL) and tumour necrosis factor-α, resulting in excessive bone resorption and rapid bone loss. 14 For senile osteoporosis, there is also a significant reduction in bone formation due to osteoblastic dysfunction. Osteoblasts and adipocytes both differentiate from mesenchymal stem cells (MSCs), and there is a shift from osteoblastogenesis to adipogenesis in the bone marrow with increasing age, causing reduction in the life span of osteoblasts.…”
Section: Introductionmentioning
confidence: 99%